Should You Hold Lifecore Biomedical (LFCR) for Long Term?
Laughing Water Capital, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Lifecore Biomedical Inc (LFCR)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Here's Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Lifecore Biomedical (LFCR) Declined in Q3
Laughing Water Capital, an investment management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Cove Street Capital Sold Lifecore Biomedical (LFCR)
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lifecore's Fiscal 2023 Fourth Quarter Earnings Call. [Operator Instructions].
Do You Think Lifecore Biomedical (LFCR) Will Get Sold for a Healthy Premium?
Greenhaven Road Capital, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here.
Lifecore Biomedical (LFCR) Does Not Face Bankruptcy Risk Now
Laughing Water Capital, an investment management company, released its second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Invest in Lifecore Biomedical (LFCR)?
Investment management company Cove Street Capital recently released its “Small Cap Value Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
What Makes Lifecore Biomedical (LFCR) an Attractive Investment Opportunity?
Laughing Water Capital, an investment management company, released its first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned 17% in the first quarter.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
